Details about the neuroanatomical projections from ORBm to RSPagl
To view more data and metadata associated with each report, click on its ID.
Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
91113 |
Orbital area medial part | Retrosplenial area lateral agranular part |
very light | biotinylated dextran amine (BDA) | Collator note: 2-3 labeled cells in ORBm. | Shibata H & Naito J., 2008 |
91156 |
Orbital area medial part | Retrosplenial area lateral agranular part |
moderate | biotinylated dextran amine (BDA) | many terminals in the lateral part of area 29d mainly at the level of the splenium of the corpus callosum (Fig. 8L–O). Small numbers of labeled terminals were also observed in area 29a (Fig. 8N,O). Collator note: label of the RSPagl and RSPd (weak). See Fig. 8M-N, Swanson Atlas Levels 35-39 | Shibata H & Naito J., 2008 |
---|
General description technique/protocol: [..] CTb injection into the lateral part of midrostrocaudal area 29d. Collator note: small CTB injection in the mid-rostrocaudal RSPagl, completely included in the region, and mapped here onto Swanson Atlas Levels 38-39. |
Further details associated to record number 91113:
Position of injection: mid-rostro-caudal |
Topological position of injection: is contained |
Extension of injection outside: none |
The injection was performed in: right hemisphere |
| Position of terminal field: everywhere |
Topological position of terminal field: is contained |
Extension of terminal field outside: none |
The terminal field was found: ipsilateral |
| |